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Abstract: Pseudorabies virus (PRV) is an alphaherpesvirus related to varicella-zoster virus (VZV) and
herpes simplex virus type 1 (HSV1). PRV is the causative agent of Aujeskzy’s disease in swine. PRV
infects mucosal epithelium and the peripheral nervous system (PNS) of its host where it can establish
a quiescent, latent infection. While the natural host of PRV is the swine, a broad spectrum of mammals,
including rodents, cats, dogs, and cattle can be infected. Since the nineteenth century, PRV infection
is known to cause a severe acute neuropathy, the so called “mad itch” in non-natural hosts, but
surprisingly not in swine. In the past, most scientific efforts have been directed to eradicating PRV from
pig farms by the use of effective marker vaccines, but little attention has been given to the processes
leading to the mad itch. The main objective of this review is to provide state-of-the-art information
on the mechanisms governing PRV-induced neuropathic itch in non-natural hosts. We highlight
similarities and key differences in the pathogenesis of PRV infections between non-natural hosts and
pigs that might explain their distinctive clinical outcomes. Current knowledge on the neurobiology
and possible explanations for the unstoppable itch experienced by PRV-infected animals is also
reviewed. We summarize recent findings concerning PRV-induced neuroinflammatory responses
in mice and address the relevance of this animal model to study other alphaherpesvirus-induced
neuropathies, such as those observed for VZV infection.
Keywords: Pseudorabies virus; neuropathic itch; immunopathogenesis; neuropathogenesis; swine;
non-natural hosts; neuroinflammation
1. History of Aujeszky’s Disease
In 1813, a disease in cattle characterized by intense itching was first described in the USA. A similar
disease appeared in Switzerland in 1849 and was mistaken for rabies because of the similar symptoms
observed in cattle and dogs. In 1902, Aladár Aujeszky, a Hungarian veterinarian, first demonstrated
the infectious nature of the agent and was able to distinguish the disease from rabies after experimental
inoculation of rabbits with tissue suspensions from a diseased ox, a dog, and a cat. The infected rabbits
showed excitation and nasal pruritus followed by convulsions and died within 60 h post-inoculation
(hpi) [1]. Thus, the disease became known as “Aujeszky’s disease” (AD). In 1910, Schmiedhoffer
confirmed that the disease was caused by a virus by performing filtration experiments [2]. From 1902
to 1930, only single outbreaks of AD were reported mainly in cattle and dogs in Hungary, Romania,
France, Russia, and Brazil and the USA. At that time, the name “pseudorabies” was given to the disease
in Europe because of its similarity to clinical rabies, while the term “mad itch” was mainly used in
the USA. In 1931, Shope finally reported that mad itch and pseudorabies were caused by the same
virus [3]. Three years later, he demonstrated that the agent of “mad itch” in cattle was also present in
swine [4]. He also noted that the disease spread in swine herd and that, if cattle were pastured in the
same lot, transmission from swine to cattle took place through abrasion of cattle skin. Surprisingly, the
disease was not transmitted from cow to cow. In 1931, the Netherlands was the first country where the
virus was reported to be enzootic in pigs. In the following years, sporadic outbreaks of PRV in pigs
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occurred worldwide and pigs were identified as a reservoir for the virus. In 1934, Sabin and Wright
reported that AD virus (ADV)/pseudorabies virus (PRV) was serologically related to herpes simplex
virus (HSV), resulting in the classification of the virus into the herpesvirus group [5–7].
2. Case Reports of Neuropathic Itch Caused by PRV Infection in Non-Natural Hosts
Since the 1950s, PRV remained a major pathogen in swine due to the intensification of pig
production worldwide, resulting in severe economic losses to the pig industry. Efforts have been
directed primarily to eradicating PRV from pig farms by the use of effective marker vaccines, but
few studies have focused on the pathogenesis of the mad itch [8]. For the most part, this is because
the characteristic pruritus observed in PRV-infected cattle and other hosts is not a common clinical
symptom in infected pigs. Although, in many European countries and in the United States, PRV has
been eliminated from domestic pigs, the virus continues to circulate among wild boar and feral swine,
which act as a reservoir for the virus.
Many cases of PRV infection in non-natural hosts have been reported since the 1950s. In this review,
we summarize all the major findings since 2004 (See Table 1). A total of 26 cases of PRV infection have
been reported involving a total of 13 humans, 50 dogs, 2 cats, 6 cattle, 863 sheep, 3 goats, 3931 captive
mink, 1 wild and 1200 captive foxes, 1 wolf, and 1 lynx. The case reports of PRV-infected animals
occurred primarily in European countries, USA and China and resulted from direct contact with pigs
while hunting or through the consumption of raw offal from infected pigs (wild and domesticated) or
pig carcasses. The main characteristic clinical symptoms observed in all infected animals were severe
pruritus in the head and neck areas accompanied by self-mutilation. All infected animals usually died
within 24–48 h after the disease onset. Gross postmortem examination of all infected animals revealed
purulent edema and inflammation of the subcutaneous tissues of the scratched area, hyperemia, and
hemorrhages. On histopathological examination, perivascular infiltrates of neutrophils, lymphocytes,
and a few macrophages were observed in the brainstem, medulla oblongata, meninges and trigeminal
ganglia (TG). Neuronal degeneration and necrosis as well as gliosis, satellitosis, and the presence
of intranuclear inclusion bodies within neurons, astrocytes and satellite cells were also noted. The
presence of infectious PRV and PRV DNA was confirmed by virus isolation, immunohistochemistry
(IHC) and polymerase chain reaction (PCR) on brain and TG samples obtained from dead animals.
In contrast, case reports for humans consisted mainly of patients hospitalized with fever, headaches,
visual impairment, seizures, respiratory failure, and coma within 1–3 days after the appearance of
the symptoms. No signs of pruritus with self-mutilation were observed. Brain magnetic resonance
imaging (MRI) and computed tomography (CT) scans showed abnormal signals in the insular cortex,
bilateral temporal lobes, and hippocampus. Patients were usually diagnosed with viral encephalitis
with the exception of one who was diagnosed with endophthalmitis. All patients immediately received
antiviral therapy (acyclovir) for approximately 2 weeks. Gross pathological examination was not
applicable as all patients survived with the exception of one who died after failing to respond to
antiviral treatment [9]. Unfortunately, an autopsy was not performed on this patient. The presence
of PRV DNA was confirmed by PCR of the vitreous humor of one patient with endophthalmitis [10].
Next generation sequencing (NGS) was used to detect only a number of 2–74 unique sequence reads
of PRV, and no other viruses, in cerebrospinal fluid (CSF) of patients. It was suggested that the use
of antivirals before detection might be the main reason for the limited number of virus sequences
detected. Serological tests confirmed the presence of PRV antibodies in the serum and CSF of those
patients. However, the presence of PRV was never determined by virus isolation from vitreous humor
or CSF samples to confirm its infectivity. Interestingly, all case reports in humans occurred in China
and mainly resulted from eye and hand injuries of patients at work (pig farms or slaughterhouses).
The high incidence of suspected human PRV infections identified here might to be related to the high
prevalence of PRV in swine in China and repeated exposure to infected animal tissues [11,12]. Still, it is
important to keep in mind that these incidences are not unique development within China or occur
just recently, as previously described by [13].
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The absence of pruritus in all infected patients resembles the clinical outcome of PRV infection
in swine and may suggest important differences in the pathogenesis of PRV among humans, swine,
and all other non-natural hosts. There is a strong evidence that PRV-induced neuropathology and
the clinical outcome of infection are connected with the innate immune response. Still, it is not clear
whether humans have developed a more controlled and effective immune response (similar to swine)
against PRV infection than other non-natural hosts. In the following sections, we will discuss in more
detail similarities and key differences in the neuropathogenesis and immunopathogenesis of PRV
infections between non-natural hosts and pigs that might explain their distinctive clinical outcomes.
3. Pseudorabies Virus (PRV)
In this section, we provide basic information about PRV taxonomy and virion structure, which is
useful to understand PRV pathogenesis. The replication cycle of PRV as well as the cell-associated
spread of infection are not covered in this review as several excellent reviews already addressed these
topics in detail [14–16].
PRV belongs to the family of the Herpesviridae, subfamily Alphaherpesvirinae, genus
Varicellovirus. The virus is closely related to herpes simplex virus type 1 and 2 (HSV1 and HSV2) and
varicella-zoster virus (VZV), causing cold sores, genital lesions, and chicken pox, respectively [17]. The
virion is 150–180 nm in diameter and comprises four main structural components: Genome, capsid,
tegument, and envelope. The viral genome consists of a linear double stranded DNA of approximately
150 kbp. The complete genome contains at least 70 open reading frames. The genome consists of
a long unique region (UL) flanked by a short inverted repeat (TRL/IRL) linked to a short unique
region (Us) flanked by an inverted repeat (TRS/IRS) [18–20]. The genome is enclosed in an icosahedral
capsid, consisting of 162 capsomers. The genome and capsid together form the nucleocapsid that is
surrounded by the tegument, a proteinaceous matrix that lines the space between the nucleocapsid and
the envelope. Tegument proteins play an important role during virus entry, assembly, and egress [21].
The envelope consists of a bilayer of phospholipids derived from the trans-Golgi network of the host
cell and contains different embedded glycoproteins. For PRV, 11 glycoproteins have been characterized
(gB, gC, gD, gE, gG, gH, gI, gK, gL, gM, and gN) and named according to the nomenclature established
for the related proteins of HSV-1 [15,16,22]. All glycoproteins are constituents of the virion, except gG,
which is secreted into the medium by infected cells [23]. The envelope proteins play important roles in
virion binding and entry, envelopment, egress, cell-to-cell spread, induction of protective immunity,
and immune evasion [15,16].
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Table 1. Case reports of neuropathic itch caused by pseudorabies virus (PRV) infection in non-natural hosts since 2004.
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Central nervous system (CNS); Trigeminal ganglia (TG); Cerebrospinal fluid (CSF); Immunohistochemistry (IHC); Immunofluorescence (IF); Hematoxylin and eosin (H&E); Next generation
sequencing (NGS); electron microscopy (EM); Polymerase chain reaction (PCR).
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4. The Pathogenesis of PRV
Here, we compare the main steps in the pathogenesis of PRV between its natural host, the swine,
and non-natural hosts that may inform the mechanisms governing PRV-induced neuropathic itch.
4.1. Introduction
PRV is a highly contagious pathogen that causes respiratory disease, neurological disorders, and
abortion in swine. Transmission occurs primarily through direct contact with oral and nasal secretions,
but can also occur by aerosols, transplacentally or venerally [49–51]. Other animal species are commonly
infected through direct contact with pigs or through the consumption of raw offal from infected pigs
(See Table 1). The infected animals develop a severe pruritus and usually die within 2 days.
4.2. Primary Replication in the Upper Respiratory Tract (URT)
Upon entry into the natural host, PRV first forms foci of infection in the epithelial cells lining
the URT, including nasal septum, tonsils, nasopharynx, trachea and lungs [14,52–54] (Figure 1(1a)).
Ex vivo experiments showed that PRV-induced foci can be detected in the epithelium of swine nasal
mucosa explants starting after 24 hpi [55,56]. Primary PRV infection of several tissues of the swine
URT results in the destruction and erosion of the epithelium, causing mild respiratory symptoms, such
as sneezing, coughing, dyspnea, and nasal discharge. These symptoms appear after 3 to 6 days and
can last up to 10 days [51]. However, infected swine usually recover quickly, except for those who
develop pneumonia due to secondary bacterial infections [57]. Viral shedding can be detected in nasal
secretions from 1 to 14 days post-inoculation (dpi) [14,58] (Figure 1(1b)).
The entry of PRV into non-natural hosts has not been well studied but the presence, in most cases,
of a pruritus in the head and neck dermatome, suggests that infectious virus particles mainly enter the
body in natural conditions via the upper respiratory tract, including the nose, mouth, sinus, larynx
and trachea (See Table 1 and Figure 2(1)). Experimental infection of mice via the intranasal route
demonstrated PRV-positive cells in the respiratory epithelium at 6 and 24 hpi by immunofluorescence
staining [7,59]. After intranasal inoculation, PRV was found in the nasal secretions of cattle and could
be isolated from the nasal and pharyngeal mucosa and tonsils of infected animals [53] (Figure 2(1a)).
Non-natural hosts can also shed PRV from nasal secretions, but only for a short time as the infected
animals die very quickly (Figure 2(1b)). PRV also can replicate in the skin of mice after skin flank and
footpad inoculations. Infectious virus was detected in the footpad around 18–24 hpi and in the skin of
the flank area at 36 hpi [60–62].
4.3. PRV Entry into the Peripheral Nervous Ssystem (PNS) Neurons and Spread to the Central Nervous
System (CNS)
After primary replication in the nasal epithelium of adult swine as described in 4.2, PRV enters
nerve endings of the PNS, including those coming from the sensory TG and olfactory bulb as well
as other facial, parasympathetic, sympathetic nerve neurons that innervate the nasal mucosa [59]
(Figure 1(1e)). Virions travel via retrograde transport to the sensory and autonomic peripheral ganglia.
A hallmark of herpesviruses is the establishment of a reactivable, latent infection in their hosts [63].
Accordingly, PRV establishes a lifelong latent infection in swine PNS neurons [64,65] (Figure 1(2)).
Meanwhile, the infected pigs recover from the respiratory disease and become asymptomatic [58,66].
Upon stress-induced reactivation, viral replication occurs in the PNS ganglia, and virions spread in the
anterograde direction along the nerves to the mucosal surfaces where the infection started [67]. Adult
swine may exhibit mild respiratory signs upon viral reactivation. PRV rarely spreads in the retrograde
direction to reach the CNS to cause encephalitis in adult swine. Cycles of latency and reactivation
in pigs result in shedding of infectious virus and transmission to uninfected animals, facilitating the
viral reservoir in herds. Interestingly, other human and animal herpesviruses, such as VZV and bovine
herpesvirus type 1 (BHV-1) have been shown to invade PNS neurons in a similar way [68,69].
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In non-natural hosts, PRV similarly enters nerve endings of the PNS that innervate the nasal
mucosa and initiates a productive infection in PNS neurons (Figure 2(1c,2)). Infectious virus and
DNA have been recovered from TG of naturally infected mink and dogs [28,30,32] (Figure 2(2a)). PRV
particles were also found by electron microscopy in satellite glia cells and PNS neurons of autonomic
ganglia from infected dogs after subcutaneous and intramuscular inoculations [70]. In contrast, a
previous study from Fields and Hills described the absence of enveloped virions within satellite
glia cells of lumbar dorsal root ganglia (DRG) after footpad inoculation, suggesting that an abortive
infection occurred in these cells [62]. It remains unclear if PRV can productively infect satellite glia
cells via transfer of virus particles from infected neurons. Following intranasal inoculation, PRV
antigens were detected in the ipsilateral TG of mice at 3 dpi [59,71]. In dogs, PRV antigens were
detected in stellate, celiac and caudal mesenteric ganglion at 4 dpi after subcutaneous inoculation [33].
Experimental inoculation of mice through the footpad and skin flank demonstrated the presence of
infectious virus in the ipsilateral DRG starting from 42 and 36 hpi, respectively [61,62]. The presence
of infectious virus suggests active viral replication in PNS neurons, which coincides with the start of
pruritus in infected animals. As non-natural hosts die very quickly after PRV infection, it is not clear
whether the virus is able to establish latency in PNS neurons. A study from Osorio and colleagues
reported successful establishment of PRV latency in TG after passive immunization of mice prior to
inoculation with an attenuated PRV strain (PRV-Bartha) [66]. The authors could recover infectious
virus from TG explants and detected PRV DNA in latently infected TG in mice by PCR and in situ
hybridization after 2 to 8 months post-inoculation. As of now, no studies have demonstrated the
establishment of latency in non-natural hosts following inoculation with a virulent PRV strain that
causes pruritus.
After replication in the PNS, progeny virions may spread in the retrograde direction from the PNS
to the CNS if the animals survive long enough. Infectious virus and viral DNA have been recovered
from brain samples of many naturally infected animals (See Table 1 and Figure 2(2b)). PRV replication
in the brain causes encephalitis. After intranasal inoculation, the virus was detected in the mouse
brainstem at 3 dpi [71]. In addition, infectious PRV was detected in the brainstem of infected mice
around 66–72 hpi following skin flank and footpad inoculations [61,62]. PRV DNA was also detected in
the spinal cord and hindbrain of infected mice at 82 hpi (moribund state) following footpad inoculation.
Interestingly, the midbrain and forebrain were rarely found positive for viral antigens, probably due to
the short survival of the animals. These findings suggested that extensive viral replication in the brain
is not responsible for the acute death of the infected animals.
4.4. PRV Replication in the Draining Lymph Nodes and Viremia
Following replication in the swine respiratory epithelium, PRV may cross the basement
membrane (BM) in foci to penetrate the connective tissues and reach the draining lymph nodes
and bloodstream [56,72] (Figure 1(1c,d)). The invasion of PRV through the BM towards the lamina
propria is mediated by trypsin-like serine protease activity [73]. Within 24–48 hpi, infectious virus
as well as viral antigens can be detected in swine inguinal lymph nodes [74–76]. Virus can persist in
pharyngeal lymph nodes for up to 35 days [77]. PRV infection is amplified in the draining lymph nodes
with discharge of infected leukocytes, via the efferent lymph, into the blood circulation. As a result, PRV
initiates a cell-associated viremia in peripheral blood mononuclear cells of swine (mainly monocytes)
that facilitates dissemination within the host (Figure 1(3)). Cell-free viremia can also occur in infected
pigs [78,79]. Viremia can be detected after 1 dpi and persists for 2 weeks. The cell-associated viremia is
a prerequisite for the dissemination of PRV to the pregnant uterus.
There are only a few studies that confirmed the presence of infectious PRV in lymph nodes
of non-natural hosts following experimental infections. In cattle, PRV could be isolated from the
retropharyngeal lymph nodes following intranasal inoculation [53]. Virus was also detected in the
pituitary, pharynx and submaxillary lymph nodes of cattle after oral infection [80]. However, PRV
was not detected in the lymph nodes of experimentally and naturally infected dogs [30,33]. So far, no
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evidence exists for cell-free or cell-associated viremia in non-natural hosts. No infectious virus was
detected in tissues other than the nervous system of infected dogs and mice [30,33,81]. In addition,
intravenous inoculation of cattle with PRV failed to disseminate the virus throughout the body.
Consequently, these results suggested that a viremia is unlikely to occur in non-natural hosts.
4.5. Secondary Replication in the Swine Pregnant Vterus
Once in the blood circulation, infected monocytes adhere to and subsequently transfer PRV to the
endothelial cells (EC) lining the blood vessels of the placenta (Figure 1(4)). Secondary replication in the
placenta can cause vasculitis and multifocal thrombosis, resulting in abortion [82–84]. The infection of
EC is mediated by cell-to-cell contacts between infected monocytes and EC [85]. The development of
abortion may depend on the hormonal activity and immune status of sows during pregnancy. Indeed,
it was demonstrated that the expression of adhesion molecules on EC is induced by cytokines and
hormones present in the local environment during pregnancy [86–88]. These cytokines may facilitate
the adhesion of infected monocytes to the endothelium.
After intranasal, intra-uterine, and intra-fetal inoculations of vaccinated pregnant sows, PRV
antigen can be detected in vaginal and sacral ganglia [89]. A widespread EC infection may cause
detachment of the fetal membranes during the first trimester of gestation, thus leading to the abortion
of a virus-negative fetus or cause fetal reabsorption in swine. Less extensive uterine vascular pathology
may allow for transplacental infection and lead to the abortion of a virus-positive fetus during the
second and third trimester of gestation or stillborn pig [51,90]. Viral aborted fetuses usually show
multiple lesions, including foci of necrosis in the liver, spleen and lungs. PRV can be isolated from the
liver, spleen, lungs, body fluids, and brain from fetuses aborted from vaccinated pregnant sows [82,91].
At this time, no cases of abortion have been described in pregnant cows, dogs or other non-natural
hosts after PRV infection. After primary replication in the nasal epithelium, a secondary replication of
PRV in the placenta of these animals is unlikely due to the absence of a cell-associated viremia.
4.6. PRV Infection in Suckling and Weaned Piglets
PRV infection is more severe in piglets than in adult swine [53]. In neonates, sudden death usually
occurs with few to no clinical signs. In suckling pigs, death is preceded by fever, vomiting and CNS
signs such as problems of coordination, weakness of the hindquarters, convulsions and paralysis.
Mortality in neonates and suckling pigs is close to 100%. In weaner pigs, clinical signs resemble those
in suckling pigs with the involvement of respiratory signs including dyspnea, sneezing, coughing, and
nasal discharge. Mortality rate is around 5–10%. No marked pruritus develops in pigs of any age.
Infectious virus could be detected in brain samples of four piglets naturally infected with PRV [92].
The severity of the symptoms decreases with age and has been correlated to a more effective immunity
in adult swine compared to that of piglets.
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5. The Pathogenesis of PRV-Induced Neuropathic Itch
In this section, we will briefly introduce the definition and clinical classification of itch and further
dissect the neuronal and immunological basics for the unstoppable itch sensation in PRV- infected animals.
5.1. Clinical Classification of Itch
Itch, also known as a pruritus, was defined in 1660 by a German physician Samuel Hafenreffler
as an “unpleasant sensation that elicits the desire or reflex to scratch”. Pruritus can be acute or
chronic [93,94]. Acute itch can be triggered by insect bites and relieved by scratching. Scratching, in
turn, generates a mild pain that inhibits the itch sensation. In contrast, chronic itch can last for a longer
period of time (>6 weeks duration) and scratching usually does not relieve the itch [95,96].
A clinical classification of chronic itch has been proposed by the International Forum for the Study
of Itch and comprised 4 categories: the pruriceptive itch, the neurogenic itch, the neuropathic itch and
the psychogenic itch (IFSI; http://www.itchforum.net). The first category is the pruriceptive itch that
is caused by inflammatory skin disorders, such as atopic dermatitis, psoriasis, drug reactions, mites,
and uticaria [97]. Pruriceptive itch originates following activation of primary afferent nerve terminals
located in the skin. The main pruritogens, or itch-producing stimuli are histamine, interleukins,
prostanglandins, and proteases. The second category is the neurogenic itch that results from CNS
activation without necessary activation of sensory nerve fibers and is usually accompanied by visceral
diseases such as chronic liver disease and chronic renal failure [98]. The third category is the neuropathic
itch, a chronic condition that arises from viral-induced disease and/or traumatic nerve injury of the
PNS or CNS, such as peripheral neuropathies (e.g., post-herpetic itch), multiple sclerosis and nerve
compression or irritation (e.g., notalgia paresthethica, and brachoradial pruritus [99]. The main
mediators of the neuropathic itch are neuropeptides, proteases and inflammatory mediators such as
cytokines. Finally, the fourth category is the psychogenic itch related to psychological or psychiatric
disorders, such as itch associated with delusions of parasitosis, stress and depression [100].
5.2. The Neuropathic Itch
Neuropathic itch (NI) is defined as perception of itch in the absence of pruritogenic stimuli [101].
NI can originate at any point along the sensory afferent pathway as a result of damage of the PNS
and less frequently of the CNS. These PNS lesions occurs in sensory itch neurons including slow
conducting myelinated (Aδ) and unmyelinated (C) nerve fibers [102]. In contrast, lesions that affect
motor neurons are not associated with NI. NI are often characterized depending on the location of the
nerve damage. For instance, brachioradial pruritus and notalgia paresthetica are focal NI, caused by
damage of small fibers within cervical spinal nerves and damage to the cutaneous branches of the
posterior divisions of the spinal nerves, respectively [103]. The most common focal NI arising from
sensory ganglia lesions occurs during VZV reactivation within sensory ganglia, initially presenting
as the zosteriform lesion known as shingles. In contrast, polyneuropathies arise from generalized
peripheral nerve damage [104]. Finally, NI syndromes can also arise from lesions within the spinal
cord (e.g., multiple sclerosis) and in the brain (stroke) [105–107]. In the brain, any types of lesions that
damage itch circuitry can cause NI.
The mechanisms underlying the neuropathic itch are still poorly understood and data are scarce.
The main consensus is that peripheral nerve injury activates PNS sensory itch neurons to fire excessively
and thus, stimulate excitative interneurons in the dorsal horn of the spinal cord to release gastrin-releasing
peptide (GRP). Then, the release of this neuropeptide further stimulates spinothalamic tract (STT) neurons
that send itch signals to the thalamus [108,109]. Finally, these signals are relayed and processed in the
somatosensory cortex. The central inhibition of itch pathway neurons in the brain that should be in turn
activated, is likely dampened or disabled, resulting in an unstoppable itch sensation [110].
5.3. The Neuronal Mechanisms of PRV-Induced Neuropathic Itch
Based on studies of the pathogenesis of PRV in non-natural hosts (see Section 4.3), continuous
PRV replication in PNS ganglia causes neuronal lesions that are likely responsible for the initiation of
Pathogens 2020, 9, 254 16 of 28
the pruritus in these animals. Several animal models have been used to further dissect the mechanisms
by which PRV replication in PNS neurons cause pruritus.
A study from Dempsher and colleagues first demonstrated that PRV induces spontaneous,
intermittent discharge of nerve impulses over the preganglionic and postganglionic nerves of superior
cervical ganglia following ocular inoculation. The spontaneous discharges were only found in PRV-infected
sympathetic ganglia of rats showing pruritus [111]. Similar results were observed after intraocular and
intradermal PRV inoculations in rats [112–114]. Interestingly, inoculation with a PRV pruritus-producing
strain (L strain) induced spontaneous hyperexcitability of neurons. In contrast, the non-pruritus
producing strain (G strain), known to cause meningoencephalitis, exhibited impaired sympathetic
synaptic conduction in infected rats [112]. Voltage-gated sodium and calcium channels were found to be
responsible for the initiation and propagation of action potential (AP) in the infected ganglia [114].
In addition, PRV infection induces electrical coupling and increases AP firing rates in cultured rat
sympathetic neurons in vitro [115]. The formation of fusion pores between infected PNS neurons was
found to be mediated by PRV gB. PRV gB protein is an important component of the viral membrane fusion
complex (gB/gH/gL) and is crucial for viral entry into neurons [116]. The production of fusion pores
facilitates the flow of ions between PNS neurons and causes direct electrical coupling [115]. Moreover,
it was demonstrated that infection of PNS neurons of the submandibular ganglia with a virulent PRV
pruritus-producing strain (PRV-Becker) induces synchronous and cyclical activity in neuronal cell
bodies [117]. Also, it was found that newly made virus particles in infected neurons were transported
in axons back to the glands where the infection started. Thus, the authors introduced the concept
of “round-trip” reseeding and amplification of the infection in the ganglia. The ability to reseed the
gland increases the infection of the innervating ganglia and the involvement of more axons in electrical
firing, therefore directly contributing to the pruritus. In contrast, mice infected with an attenuated, live
vaccine and non-pruritus producing strain (PRV-Bartha) did not show signs of synchronous and cyclical
activity in infected ganglia. This difference was attributed to the fact that PRV-Bartha lacks the US9
protein required for sorting virion proteins into axons [118]. Recent results are in agreement with the
PRV round-trip concept. For instance, a large amount of infectious virus was detected in the mouse
footpad at moribund state after footpad inoculation. Likely, it resulted from virus particles that originally
infected the DRG, replicated and went back to the footpad rather than from local viral replication in the
footpad. Indeed, the inoculated footpad, which exhibited epidermal necrosis accompanied by immune
cell infiltrates, did not have time to regenerate and support efficient viral replication [81].
Finally, a comparative study of the neuroinvasive mechanisms between virulent PRV-Becker
and attenuated PRV-Bartha was performed using the mouse flank inoculation model. In contrast to
PRV-Becker infection, mice infected with PRV-Bartha did not develop pruritus and lived twice as long.
However, they did show severe CNS symptoms due to widespread PRV-Bartha infection in the brain
and eventually died of viral encephalitis. Using several PRV mutants, the authors demonstrated that
the pruritus stimulus was mainly mediated by US9, gE and gI proteins [61]. These 3 gene products,
which are deleted in the PRV-Bartha strain, are required for virulence and efficient anterograde spread
of PRV within the nervous system [118–120].
5.4. The Immune Mechanisms of PRV-Induced Neuropathic Itch
The immune system plays a crucial role in the development of neuropathic itch. In the case of a
pruriceptive itch, skin inflammation results in the recruitment and activation of immune cells to the
skin epithelium. Activated immune cells release pro-inflammatory mediators, such as interleukin
(IL) 31 and IL-33 that sensitize pruriceptors, leading to peripheral sensitization and activation of
itch signaling pathways [121]. In the case of a neuropathic itch, peripheral nerve injury can cause
inflammation of the nervous system, so called neuroinflammation. The PNS and CNS neurons as
well as resident satellite glia, microglia, and astrocytes can also produce inflammatory mediators,
including pro-inflammatory cytokines and chemokines, neuropeptides and reactive oxygen species.
The release of neuropeptides such as substance P and calcitonin gene-related peptide (CGRP) by
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activated primary sensory neurons has been shown to have paracrine effects on immune cells and can
increase the inflammation and subsequently amplify the itch sensation [122,123]. The same localized
immune activation can be mimicked after viral infection of PNS neurons. For instance, reactivation
of VZV from sensory ganglia causes a self-limited dermatomal rash with pain and itching, which is
accompanied by inflammation of the skin [124].
Several cases of PRV-induced neuropathic itch reported mild purulent ganglioneuritis and
encephalomyelitis in non-natural hosts, thus suggesting that PRV infection of sensory ganglia is
accompanied by a specific inflammatory response (See Table 1). Indeed, perivascular cuffing of
lymphocytes, monocytes and macrophages as well as a neutrophilic cell infiltration were detected in
PRV-infected ganglia. So far, only a few studies investigated the role of the inflammatory response in the
initiation and development of PRV-induced neuropathic itch. By the use of the mouse flank inoculation
model, PRV-Becker infected mice, that were anesthetized at the time the pruritus started, did not
develop skin lesions. Still, these mice died as the same time as the non-anesthetized ones. These results
suggested that self-mutilation and scratching alone were not the cause of death. The authors then
mentioned that a peripheral host immune response to PRV infection of the PNS could be an important
factor in the death of the infected animals [61]. Using the footpad inoculation model, it was later
shown that virulent PRV-Becker, but not attenuated PRV-Bartha, infection induces a specific and lethal
systemic inflammatory response in mice. High levels of IL-6 and granulocyte colony-stimulating factor
(G-CSF) were measured in both tissues and plasma of infected animals, including the footpad and DRG
at moribund stage [81]. Furthermore, a strong correlation was found between the level of infectious
virus detected in the DRG and footpad and the production of pro-inflammatory cytokines. Indeed,
PRV-Becker replicated to a higher level in both tissues than PRV-Bartha. The fact that PRV-Becker
was able to reseed new progeny virions back from the DRG neurons to the footpad might also have
contributed to the amplification of the inflammatory response. Figure 3 shows a model of PRV-induced
neuropathic itch in non-natural hosts.
Both IL-6 and G-CSF are produced by immune cells (neutrophils, T lymphocytes and macrophages)
and neurons. While IL-6 has pleiotropic effects on immune response, inflammation, hematopoiesis and
neurogenesis, G-CSF is mainly a key regulator of neutrophil function, mainly influencing the migration
of neutrophils across the vascular endothelium [125–127]. Taken together, the high concentrations of
G-CSF and IL-6 detected in the infected footpad and DRG of experimentally infected mice are likely
to correlate with histological findings from naturally infected animals where a massive neutrophilic
infiltration is observed in the PRV-infected ganglia. Furthermore, neutrophils can induce neurotoxicity
on DRG neurons and are considered responsible for hypersensitivity and neuropathic pain observed
after peripheral nerve injury [128]. Therefore, their accumulation around the infected ganglia may
further amplify the neuroinflammation.
The early events of the neuroinflammatory response of PRV infection in mice were recently
characterized. Using the mouse footpad inoculation model, it was demonstrated that PRV-Becker
infection primes DRG neurons to a state of inflammation very early post-infection [60]. More specifically,
the authors found that the peak of IL-6 and G-CSF production detected in the DRGs and footpad of
infected mice at 7 hpi could not be attributed to the infiltration of neutrophils in these tissues that
occurred at 82 hpi. An efficient replication of PRV-Becker and subsequent spread in the footpad
were necessary to activate DRG neurons to produce G-CSF at a very early time pi. Moreover, PRV
replication was limited in the footpad of Toll-like receptor 2 (TLR2) knockout (KO) mice with no viral
replication detected in DRG neurons. TLRs are expressed in nociceptive neurons and play a crucial
role in neuroinflammation [129,130]. In particular, TLR2 is responsible for the activation of spinal cord
glial cell after nerve injury and subsequent pain hypersensitivity [131]. Thus, the results suggested
that TLR2 might be a potential receptor for PRV on DRG neurons, thus facilitating viral spread and the
initiation of the neuroinflammatory response in mice. PRV gB expressed on new progeny virions or
infected epidermal cells was proposed as a potential candidate to interact with TLR2 expressed on
axon terminals of DRG neurons that are innervating the footpad.
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5.5. Why PRV-Infected Swine Do Not Itch
As described in Section 4, the pathogenesis of PRV is very different between its natural host,
the pig, and other mammals. One first essential difference is the establishment of latency in PNS
neurons of pigs followed by sporadic periods of reactivation. In contrast, PRV productively replicates
in PNS neurons of non-natural hosts following primary infection of the URT and the infection can
spread further to the CNS. A latent infection is not established. The second main difference is that
productive PRV infection of PNS neurons triggers a specific inflammatory response that contributes to
the initiation and development of the pruritus in non-natural hosts.
Using compartmented rat neuronal cultures, it was demonstrated that efficient PRV retrograde
transport in axons depends on the number of virus particles infecting axons. A threshold for the number
of infecting particles in axons is set for establishing a quiescent (below a MOI of 0.1) or productive
(above a MOI of 0.1) infection in rodent PNS neurons [132]. A similar threshold of PRV infection may
exist in pigs. Better immune control of the infection at the primary site, the URT, may limit the number
of PRV particles reaching the cell bodies of swine PNS neurons facilitating the latent infection.
Interestingly, type I IFN suppresses PRV production replication in porcine TG neurons and porcine
epithelial cells in vitro [133,134]. All PRV-infected TG neurons were in a stably suppressed quiescent
state of infection after type I IFN pretreatment. More specifically, it was demonstrated that type I IFN
decreases PRV IE180 protein expression level in sensory neuronal cells, allowing for the establishment
of a quiescent state [135]. Pretreatment of axons with type I IFN significantly reduced the number of
PRV particles moving in axons towards the cell bodies of rat PNS neurons [136]. In addition, Lamote
and colleagues demonstrated that PRV-Becker inhibits the IFN response in swine dendritic cells while
PRV-Bartha induces a strong type I IFN response in these cells. This difference was attributed to the
absence of the immunomodulatory glycoprotein gE/gI gene complex, in the genome of Bartha [137].
So far, the level of type I IFN has not been quantified in the swine URT and compared between PRV-Becker
and PRV-Bartha infections. Therefore, it is not known whether the PRV gE/gI complex similarly inhibits
the type I IFN response in the swine respiratory epithelium. If so, additional antiviral factors, other than
the induction of a strong type I IFN response, may exist further restricting primary PRV infection in pigs.
For instance, a group of antiviral restriction factors, the IFN-inducible transmembrane proteins (IFITMs)
have been shown to inhibit PRV replication in porcine kidney epithelial (PK-15) cells and porcine
alveolar macrophages. Porcine IFTM1 specifically inhibited PRV entry in these cells [138]. Furthermore,
a porcine IFN-stimulated ubiquitin-like protein (pISG15) efficiently inhibited PRV infection by reducing
viral titers and increasing type I IFN expression in vitro [139].
In addition to its role in reducing viral replication, type I IFN plays a crucial role in regulating the
early neuroinflammatory response and clinical outcome of PRV infection in mice [60]. In the footpad
inoculation model, PRV-Bartha infection, but not PRV-Becker, induces a strong type I IFN response in the
footpad and DRG neurons of inoculated mice, which in turn fails to trigger an inflammatory response
in those tissues. Surprisingly, PRV-Bartha infection of type I IFN KO mice induces the production of
pro-inflammatory cytokines, such as G-CSF in DRG neurons. Therefore, PRV-Becker infection may
trigger a massive inflammatory response in mice because this virulent strain can suppress the IFN
response. The imbalance of pro-inflammatory and antiviral immune responses might contribute to the
distinct clinical outcomes of PRV-Becker and Bartha infections in mice. In addition, during PRV-Becker
infection, the rapid priming of DRG neurons to an inflammatory state may initiate the neuropathic itch
in mice as the infection of the PNS proceeds.
Taken together, these studies emphasize the essential role of the type I IFN response in controlling
PRV replication in the swine respiratory epithelium. This control may prevent the productive PNS
infection and the induction of a powerful inflammatory response, which may be the reason why
infected pigs do not show itch symptoms.
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cytokines that are released in PNS neurons and locally at axon terminals. (2) (d) Efficient PRV replication in cell bodies of PNS neurons and release of new progeny
virions; (e) Spontaneous hyperexcitability of neurons and increase of action potential firing as well as (f) reseeding of new progeny virions back to the epithelium
increases electrical coupling of axons and contributes to the pruritus; (b) Amplification of the inflammatory response in PNS neurons; (h) The production of
pro-inflammatory cytokines in PNS neurons attract neutrophils and other immune cells to the site of infection and propagate the neuroinflammation. (3) (i) Release of
neuropeptides from activated PNS neurons stimulate excitative interneurons in the dorsal horn of the spinal cord; (j) The excitation spreads to spinothalamic tract
neurons, which in turn send neuroinflammatory itch signals to the brain; (k) These signals are relayed and processed in the somatosensory cortex. (4) The central itch
inhibition pathways are likely dampened or disabled, resulting in an unstoppable pruritus.
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6. PRV Infection in Mice: A New Animal Model for VZV-Induced Peripheral Neuropathies
A better understanding of PRV-induced neuroinflammatory responses in mice may provide
new insights in the initiation and development of virus-induced neuroinflammation during other
herpesvirus infections. For instance, this animal model could be useful to dissect the mechanisms of
neuropathic itch in patients with post-herpetic lesions (e.g., herpes zoster (HZ); shingles). Indeed,
the neuropathogenesis and immunopathogenesis of VZV and PRV infections are remarkably similar.
Reactivation of VZV causes a self-limited dermatomal rash with pain and itching, which is accompanied
by inflammation of the skin [124]. The HZ lesions can be reduced by treatment with antivirals [140].
However, postherpetic neuralgia (PHN) and postherpetic itch (PHI) are two common complications of
HZ that can occur in some cases in up to 50% of patients with shingles [101,141].
PHN consists of a burning and stabbing pain while PHI is characterized by a relentless itch in the
same area of the HZ rash, resulting in serious injuries due to scratching. Both PHN and PHI can last
for months or years after resolution of the HZ rash, thus severely impacting the life quality of infected
people. Antiviral therapy for acute HZ does not eliminate the risk of PHN, and no beneficial effect of
any antiviral drug on established PHN has been shown [142]. It was suggested that PHN is caused
by VZV-induced inflammation and axonal damage, which gives rise to hyperexcitability, marked by
spontaneous firing of PNS neurons. These neurons may have a lower excitation threshold to pain,
thus causing neuropathic pain [143,144]. In contrast, the underlying mechanism(s) of PHI is largely
unknown. Despite some similarities between itch and pain pathways, treatments against pain are
not efficient in relieving itch. Current treatments against neuropathic itch are very limited and lack
specificity, and for many patients with PHI no alleviation can be provided [145].
The narrow host range and lack of clinical disease have limited the use of animal models to
investigate the pathogenesis of VZV infection [146]. So far, investigation of PHI has been limited by
the lack of a relevant in vivo neuropathic itch animal model. Interestingly, VZV and PRV infections
present multiple similarities in genome sequence, clinical signs, pathogenesis and immunity. At the
level of innate immunity, the exact same concentration of IL-6 (~30,000 pg/mL) has been demonstrated
in both VZV-infected human explants and PRV-infected mouse footpad by ELISA [81,147]. Since VZV
does not productively replicate in rodents, PRV-induced neuropathic itch in mice may represent a
promising model to further understand the pathogenesis of PHI caused by VZV infection.
7. Conclusions
Since the first case of mad itch was described 207 years ago, the characteristic pruritus caused
by PRV infection in non-natural hosts has been frequently reported throughout the years. Currently,
relatively few studies have focused on this particular aspect of PRV pathogenesis. This paucity of
information is mainly because PRV remained a major viral disease in swine, causing substantial
economic losses to pig producers. Therefore, the efforts of the research community were primarily
focused on developing effective vaccines aimed at eradication of the virus. In this review, we highlight
the more fundamental studies that focus on differences in the pathogenesis of PRV between pigs and
non-natural hosts. These studies may explain the distinct clinical outcomes. Recently, researchers
dissected the molecular and cellular mechanisms of PRV-induced neuropathic itch using several
mouse models and emphasized the innate immune response as a central player. Good control of
the inflammatory response during PRV infection of swine likely prevents the neuropathic pruritus
experienced by infected non-natural hosts. Most importantly, PRV infection of mice has proven to
be a suitable animal model to study PRV-induced neuropathic itch. This animal model may also
provide useful insights into the pathogenesis of other herpesvirus infections, such as those following
VZV infection. The model may lead to the development of innovative therapeutic strategies. Finally,
this model may guide research on peripheral neuropathies such as multiple sclerosis and associated
viral-induced damage to the PNS as well as other neurodegenerative processes.
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42. Lazic, G.; Lupulovic, D.; Topalski, B.; Bozić, B.; Lazic, S. Aujeszky’s disease in a dog—Case report. Arh. Vet.
Med. 2017, 10, 61–69.
Pathogens 2020, 9, 254 24 of 28
43. Serena, M.S.; Metz, G.E.; Lozada, M.I.; Aspitia, C.G.; Nicolino, E.H.; Pidone, C.L.; Fossaroli, M.; Balsalobre, A.;
Quiroga, M.A.; Echeverria, M.G. First isolation and molecular characterization of Suid herpesvirus type 1
from a domestic dog in Argentina. Open Vet. J. 2018, 8, 131–139. [CrossRef] [PubMed]
44. Cheng, Z.; Kong, Z.; Liu, P.; Fu, Z.; Zhang, J.; Liu, M.; Shang, Y. Natural infection of a variant pseudorabies
virus leads to bovine death in China. Transbound Emerg Dis. 2019. [CrossRef] [PubMed]
45. Yang, H.; Han, H.; Wang, H.; Cui, Y.; Liu, H.; Ding, S.A. Case of Human Viral Encephalitis Caused by
Pseudorabies Virus Infection in China. Front. Neurol. 2019, 10, 534. [CrossRef] [PubMed]
46. Yang, X.; Guan, H.; Li, C.; Li, Y.; Wang, S.; Zhao, X.; Zhao, Y.; Liu, Y. Characteristics of human encephalitis
caused by pseudorabies virus: A case series study. Int. J. Infect. Dis. 2019, 87, 92–99. [CrossRef]
47. Wang, Y.; Nian, H.; Li, Z.; Wang, W.; Wang, X.; Cui, Y. Human encephalitis complicated with bilateral acute
retinal necrosis associated with pseudorabies virus infection: A case report. Int. J. Infect. Dis. 2019, 89, 51–54.
[CrossRef]
48. Wang, D.; Tao, X.; Fei, M.; Chen, J.; Guo, W.; Li, P.; Wang, J. Human encephalitis caused by pseudorabies
virus infection: A case report. J. Neurovirol. 2020. [CrossRef]
49. Hahn, E.C.; Page, G.R.; Hahn, P.S.; Gillis, K.D.; Romero, C.; Annelli, J.A.; Gibbs, E.P. Mechanisms of
transmission of Aujeszky’s disease virus originating from feral swine in the USA. Vet. Microbiol. 1997, 55,
123–130. [CrossRef]
50. Romero, C.H.; Meade, P.N.; Shultz, J.E.; Chung, H.Y.; Gibbs, E.P.; Hahn, E.C.; Lollis, G. Venereal transmission
of pseudorabies viruses indigenous to feral swine. J. Wildl. Dis. 2001, 37, 289–296. [CrossRef]
51. Kluge, J.P.; Beran, G.W.; Hill, H.T.; Platt, K.B. Pseudorabies (Aujeszky’s Disease). In Diseases of swine, 8th ed.;
Straw, B.E., D’Allaire, S., Mengeling, W.L., Taylor, D.J., Eds.; Iowa State University Press: Ames, IA, USA,
1999; pp. 233–246.
52. Miry, C.P. Aujeszky’s Disease Virus Replication in Tonsils and Respiratory Tract of non-Immune and Immune
Pigs. In Vaccination and Control of Aujeszky’s disease; van Oirschot, J.T., Ed.; Kluwer Academic Publishers:
Dordrecht, The Netherlands, 1989; pp. 163–173.
53. Wittmann, G. Aujeszky’s Disease (Pseudorabies) in Pigs. In Herpesvirus Diseases of Cattle, Horses and Pigs;
Knipe, D.M., Howley, P.M., Eds.; Kluwer Academic Publishers: Boston, MA, USA, 1989; pp. 230–325.
54. Masic, M.; Ercegan, M.; Petrovic, M. The significance of the tonsils in the pathogenesis and diagnosis of
Aujeszyk’s disease in pigs. Zent. Vet. B 1965, 12, 398–405.
55. Glorieux, S.; Van den Broeck, W.; van der Meulen, K.M.; Van Reeth, K.; Favoreel, H.W.; Nauwynck, H.J.
In vitro culture of porcine respiratory nasal mucosa explants for studying the interaction of porcine viruses
with the respiratory tract. J. Virol. Methods 2007, 142, 105–112. [CrossRef]
56. Glorieux, S.; Favoreel, H.W.; Meesen, G.; de Vos, W.; Van den Broeck, W.; Nauwynck, H.J. Different
replication characteristics of historical pseudorabies virus strains in porcine respiratory nasal mucosa
explants. Vet. Microbiol. 2009, 136, 341–346. [CrossRef] [PubMed]
57. Narita, M.; Kawashima, K.; Matsuura, S.; Uchimura, A.; Miura, Y. Pneumonia in pigs infected with
pseudorabies virus and Haemophilus parasuis serovar 4. J. Comp. Pathol. 1994, 110, 329–339. [CrossRef]
58. Maes, R.K.; Kanitz, C.L.; Gustafson, D.P. Shedding patterns in swine of virulent and attenuated pseudorabies
virus. Am. J. Vet. Res. 1983, 44, 2083–2086. [PubMed]
59. Babic, N.; Mettenleiter, T.C.; Ugolini, G.; Flamand, A.; Coulon, P. Propagation of pseudorabies virus in the
nervous system of the mouse after intranasal inoculation. Virology 1994, 204, 616–625. [CrossRef] [PubMed]
60. Laval, K.; Van Cleemput, J.; Vernejoul, J.B.; Enquist, L.W. Alphaherpesvirus infection of mice primes PNS
neurons to an inflammatory state regulated by TLR2 and type I IFN signaling. PLoS Pathog. 2019, 15,
e1008087. [CrossRef]
61. Brittle, E.E.; Reynolds, A.E.; Enquist, L.W. Two modes of pseudorabies virus neuroinvasion and lethality in
mice. J. Virol. 2004, 78, 12951–12963. [CrossRef]
62. Field, H.J.; Hill, T.J. The pathogenesis of pseudorabies in mice following peripheral inoculation. J. Gen. Virol.
1974, 23, 145–157. [CrossRef]
63. Grinde, B. Herpesviruses: Latency and reactivation—Viral strategies and host response. J. Oral Microbiol.
2013, 5. [CrossRef]
64. Tirabassi, R.S.; Townley, R.A.; Eldridge, M.G.; Enquist, L.W. Molecular mechanisms of neurotropic herpesvirus
invasion and spread in the CNS. Neurosci. Biobehav. Rev. 1998, 22, 709–720. [CrossRef]
Pathogens 2020, 9, 254 25 of 28
65. Gutekunst, D.E.; Pirtle, E.C.; Miller, L.D.; Stewart, W.C. Isolation of pseudorabies virus from trigeminal
ganglia of a latently infected sow. Am. J. Vet. Res. 1980, 41, 1315–1316.
66. Wheeler, J.G.; Osorio, F.A. Investigation of sites of pseudorabies virus latency, using polymerase chain
reaction. Am. J. Vet. Res. 1991, 52, 1799–1803. [PubMed]
67. Van Oirschot, J.T.; Gielkens, A.L. In vivo and in vitro reactivation of latent pseudorabies virus in pigs born to
vaccinated sows. Am. J. Vet. Res. 1984, 45, 567–571. [PubMed]
68. Wigdahl, B.; Rong, B.L.; Kinney-Thomas, E. Varicella-zoster virus infection of human sensory neurons.
Virology 1986, 152, 384–399. [CrossRef]
69. Jones, C. Bovine Herpes Virus 1 (BHV-1) and Herpes Simplex Virus Type 1 (HSV-1) Promote Survival of
Latently Infected Sensory Neurons, in Part by Inhibiting Apoptosis. J. Cell Death 2013, 6, 1–16. [CrossRef]
70. Olson, G.R.; Miller, L.D. Studies on the pathogenesis of heart lesions in dogs infected with pseudorabies
virus. Can. J. Vet. Res. 1986, 50, 245–250.
71. Damann, N.; Klopfleisch, R.; Rothermel, M.; Doerner, J.F.; Mettenleiter, T.C.; Hatt, H.; Wetzel, C.H. Neuronal
pathways of viral invasion in mice after intranasal inoculation of pseudorabies virus PrV-9112C2 expressing
bovine herpesvirus 1 glycoprotein B. J. Neurovirol. 2006, 12, 60–64. [CrossRef]
72. Lamote, J.A.S.; Glorieux, S.; Nauwynck, H.J.; Favoreel, H.W. The US3 Protein of Pseudorabies Virus Drives
Viral Passage across the Basement Membrane in Porcine Respiratory Mucosa Explants. J. Virol. 2016, 90,
10945–10950. [CrossRef]
73. Glorieux, S.; Favoreel, H.W.; Steukers, L.; Vandekerckhove, A.P.; Nauwynck, H.J. A trypsin-like serine
protease is involved in pseudorabies virus invasion through the basement membrane barrier of porcine nasal
respiratory mucosa. Vet. Res. 2011, 42, 58. [CrossRef]
74. Jamrichova, O.; Skoda, R. Multiplication of pseudorabies virus in the inguinal lymph nodes of pigs. Acta Virol.
1968, 12, 555.
75. Wittmann, G.; Ohlinger, V.; Rziha, H.J. Occurrence and reactivation of latent Aujeszky’s disease virus
following challenge in previously vaccinated pigs. Arch. Virol. 1983, 75, 29–41. [CrossRef]
76. Mulder, W.A.; Jacobs, L.; Priem, J.; Kok, G.L.; Wagenaar, F.; Kimman, T.G.; Pol, J.M. Glycoprotein gE-negative
pseudorabies virus has a reduced capability to infect second- and third-order neurons of the olfactory and
trigeminal routes in the porcine central nervous system. J. Gen. Virol. 1994, 75, 3095–3106. [CrossRef]
[PubMed]
77. Sabo, A.; Rajcani, J.; Blaskovic, D. Studies on the pathogenesis of Aujeszky’s disease virus. III. The distribution
of virulent virus in piglets after intranasal infection. Acta Virol. 1969, 13, 407–714. [PubMed]
78. Nauwynck, H.J.; Pensaert, M.B. Interactions of Aujeszky’s disease virus and porcine blood mononuclear
cells in vivo and in vitro. Acta Vet. Hung. 1994, 42, 301–308. [PubMed]
79. Nawynck, H.J.; Pensaert, M.B. Cell-free and cell-associated viremia in pigs after oronasal infection with
Aujeszky’s disease virus. Vet. Microbiol. 1995, 43, 307–314. [CrossRef]
80. Mc Ferran, I.B.; Dow, C. Virus studies on experimental Aujeszky’s disease in calves. J. Comp. Pathol. 1964, 74,
173–179. [CrossRef]
81. Laval, K.; Vernejoul, J.B.; Van Cleemput, J.; Koyuncu, O.O.; Enquist, L.W. Virulent Pseudorabies Virus
Infection Induces a Specific and Lethal Systemic Inflammatory Response in Mice. J. Virol. 2018, 92, e01614-18.
[CrossRef]
82. Nauwynck, H.J.; Pensaert, M.B. Abortion induced by cell-associated pseudorabies virus in vaccinated sows.
Am. J. Vet. Res. 1992, 53, 489–493.
83. Kluge, J.P.; Mare, C.J. Swine pseudorabies: Abortion, clinical disease, and lesions in pregnant gilts infected
with pseudorabies virus (Aujeszky’s disease). Am. J. Vet. Res. 1974, 35, 991–995.
84. Hsu, F.S.; Chu, R.M.; Lee, R.C.; Chu, S.H. Placental lesions caused by pseudorabies virus in pregnant sows.
J. Am. Vet. Med. Assoc. 1980, 177, 636–641.
85. Van de Walle, G.R.; Favoreel, H.W.; Nauwynck, H.J.; Mettenleiter, T.C.; Pensaert, M.B. Transmission of
pseudorabies virus from immune-masked blood monocytes to endothelial cells. J. Gen. Virol. 2003, 84,
629–637. [CrossRef]
86. Ka, H.; Seo, H.; Choi, Y.; Yoo, I.; Han, J. Endometrial response to conceptus-derived estrogen and interleukin-1β
at the time of implantation in pigs. J. Anim. Sci. Biotechnol. 2018, 9, 44. [CrossRef] [PubMed]
87. Velez, C.; Barbeito, C.; Koncurat, M. alphavbeta3 Integrin and fibronectin expressions and their relation to
estrogen and progesterone during placentation in swine. Biotech. Histochem. 2018, 93, 15–24. [PubMed]
Pathogens 2020, 9, 254 26 of 28
88. Bidarimath, M.; Tayade, C. Pregnancy and spontaneous fetal loss: A pig perspective. Mol. Reprod. Dev. 2017,
84, 856–869. [CrossRef] [PubMed]
89. Dieuzy, I.; Vannier, P.; Jestin, A. Effects of experimental pseudorabies virus infection on vaccinated pregnant
sows. Ann. Rech. Vet. 1987, 18, 233–240.
90. Iglesias, J.G.; Harkness, J.W. Studies of transplacental and perinatal infection with two clones of a single
Aujeszky’s disease (pseudorabies) virus isolate. Vet. Microbiol. 1988, 16, 243–254. [CrossRef]
91. Ceriatti, F.S.; Sabini, L.I.; Bettera, S.G.; Zanon, S.M.; Ramos, B.A. Experimental infection of pregnant gilts
with Aujeszky’s disease virus strain RC/79. Rev. Argent Microbiol. 1992, 24, 102–112.
92. Ezura, K.; Usami, Y.; Tajima, K.; Komaniwa, H.; Nagai, S.; Narita, M.; Kawashima, K. Gastrointestinal and
skin lesions in piglets naturally infected with pseudorabies virus. J. Vet. Diagn. Investig. 1995, 7, 451–455.
[CrossRef]
93. Ständer, S.; Weisshaar, E.; Mettang, T.; Szepietowski, J.C.; Carstens, E.; Ikoma, A.; Bergasa, N.V.; Gieler, U.;
Misery, L.; Wallengren, J.; et al. Clinical classification of itch: A position paper of the International Forum for
the Study of Itch. Acta Derm. Venereol. 2007, 87, 291–294. [CrossRef]
94. Ikoma, A.; Steinhoff, M.; Ständer, S.; Yosipovitch, G.; Schmelz, M. The neurobiology of itch. Nat. Rev.
Neurosci. 2006, 7, 535–547. [CrossRef]
95. Grundmann, S.; Stander, S. Chronic pruritus: Clinics and treatment. Ann. Dermatol. 2011, 23, 1–11. [CrossRef]
96. Green, D.; Dong, X. The cell biology of acute itch. J. Cell. Biol. 2016, 213, 155–161. [CrossRef] [PubMed]
97. Yosipovitch, G.; Fleischer, A. Itch associated with skin disease: Advances in pathophysiology and emerging
therapies. Am. J. Clin. Dermatol. 2003, 4, 617–622. [CrossRef] [PubMed]
98. Galatian, A.; Stearns, G.; Grau, R. Pruritus in connective tissue and other common systemic disease states.
Cutis 2009, 84, 207–214. [PubMed]
99. Binder, A.; Koroschetz, J.; Baron, R. Disease mechanisms in neuropathic itch. Nat. Clin. Pract. Neurol. 2008, 4,
329–337. [CrossRef]
100. Yosipovitch, G.; Samuel, L.S. Neuropathic and psychogenic itch. Dermatol. Ther. 2008, 21, 32–41. [CrossRef]
101. Oaklander, A.L. Neuropathic itch. Semin. Cutan. Med. Surg. 2011, 30, 87–92. [CrossRef]
102. Ringkamp, M.; Meyer, R. Itch: Mechanisms and treatment; Carstens, E., Akiyama, T., Eds.; Frontiers in
Neuroscience Pruriceptors; CRC Press/Taylor & Francis(c), LLC: Boca Raton, FL, USA, 2014.
103. Robbins, B.A.; Schmieder, G.J. Brachioradial Pruritus. In StatPearls; StatPearls Publishing StatPearls
Publishing LLC.: Treasure Island, FL, USA, 2020.
104. Mittal, A.; Srivastava, A.; Balai, M.; Khare, A.K. A study of postherpetic pruritus. Indian Dermatol. Online J.
2016, 7, 343–344. [CrossRef]
105. Yamamoto, M.; Yabuki, S.; Hayabara, T.; Otsuki, S. Paroxysmal itching in multiple sclerosis: A report of three
cases. J. Neurol. Neurosurg. Psychiatry 1981, 44, 19–22. [CrossRef]
106. Koeppel, M.C.; Bramont, C.; Ceccaldi, M.; Habib, M.; Sayag, J. Paroxysmal pruritus and multiple sclerosis.
Br. J. Dermatol. 1993, 129, 597–598. [CrossRef]
107. King, C.A.; Huff, F.J.; Jorizzo, J.L. Unilateral neurogenic pruritus: Paroxysmal itching associated with central
nervous system lesions. Ann. Intern. Med. 1982, 97, 222–223. [CrossRef]
108. Steinhoff, M.; Schmelz, M.; Szabó, I.L.; Oaklander, A.L. Clinical presentation, management, and
pathophysiology of neuropathic itch. Lancet Neurol. 2018, 17, 709–720. [CrossRef]
109. Davidson, S.; Zhang, X.; Khasabov, S.G.; Simone, D.A.; Giesler, G.J., Jr. Relief of itch by scratching:
State-dependent inhibition of primate spinothalamic tract neurons. Nat. Neurosci. 2009, 12, 544–546.
[CrossRef] [PubMed]
110. Yosipovitch, G.; Ishiuji, Y.; Patel, T.S.; Hicks, M.I.; Oshiro, Y.; Kraft, R.A.; Winnicki, E.; Coghill, R.C. The Brain
Processing of Scratching. J. Investig. Dermatol. 2019, 128, 1806–1811. [CrossRef] [PubMed]
111. Dempsher, J.; Larrabee, M.G.; Bang, F.B.; Bodian, D. Physiological changes in sympathetic ganglia infected
with pseudorabies virus. Am. J. Physiol. 1955, 182, 203–216. [CrossRef]
112. Tokumaru, T. Pseudorabies virus—Induced neural hyperreactivity following occular and skin infections in
the rat. Res. Commun. Chem. Pathol. Pharmacol. 1975, 10, 533–542.
113. Dolivo, M.; Beretta, E.; Bonifas, V.; Foroglou, C. Ultrastructure and function in sympathetic ganglia isolated
from rats infected with pseudorabies virus. Brain Res. 1978, 140, 111–123. [CrossRef]
114. Liao, G.S.; Maillard, M.; Kiraly, M. Ion channels involved in the presynaptic hyperexcitability induced by
herpes virus suid in rat superior cervical ganglion. Neuroscience 1991, 41, 797–807. [CrossRef]
Pathogens 2020, 9, 254 27 of 28
115. McCarthy, K.M.; Tank, D.W.; Enquist, L.W. Pseudorabies virus infection alters neuronal activity and
connectivity in vitro. PLoS Pathog. 2009, 5, e1000640. [CrossRef]
116. Favoreel, H.W.; Van Minnebruggen, G.; Nauwynck, H.J.; Enquist, L.W.; Pensaert, M.B. A tyrosine-based
motif in the cytoplasmic tail of pseudorabies virus glycoprotein B is important for both antibody-induced
internalization of viral glycoproteins and efficient cell-to-cell spread. J. Virol. 2002, 76, 6845–6851. [CrossRef]
117. Granstedt, A.E.; Bosse, J.B.; Thiberge, S.Y.; Enquist, L.W. In vivo imaging of alphaherpesvirus infection
reveals synchronized activity dependent on axonal sorting of viral proteins. Proc. Natl. Acad. Sci. USA 2013,
110, E3516–E3525. [CrossRef]
118. Brideau, A.D.; Card, J.P.; Enquist, L.W. Role of pseudorabies virus Us9, a type II membrane protein, in
infection of tissue culture cells and the rat nervous system. J. Virol. 2000, 74, 834–845. [CrossRef] [PubMed]
119. Husak, P.J.; Kuo, T.; Enquist, L.W. Pseudorabies virus membrane proteins gI and gE facilitate anterograde
spread of infection in projection-specific neurons in the rat. J. Virol. 2000, 74, 10975–10983. [CrossRef]
[PubMed]
120. Yang, M.; Card, J.P.; Tirabassi, R.S.; Miselis, R.R.; Enquist, L.W. Retrograde, transneuronal spread of
pseudorabies virus in defined neuronal circuitry of the rat brain is facilitated by gE mutations that reduce
virulence. J. Virol. 1999, 73, 4350–4359. [CrossRef] [PubMed]
121. Schmelz, M. Itch Processing in the Skin. Front. Med. 2019, 6, 167. [CrossRef] [PubMed]
122. Iyengar, S.; Ossipov, M.H.; Johnson, K.W. The role of calcitonin gene-related peptide in peripheral and central
pain mechanisms including migraine. Pain 2017, 158, 543–559. [CrossRef] [PubMed]
123. Wang, X.F.; Ge, T.T.; Fan, J.; Yang, W.; Cui, R.J. The role of substance P in epilepsy and seizure disorders.
Oncotarget 2017, 8, 78225–78233. [CrossRef] [PubMed]
124. Mueller, N.H.; Gilden, D.H.; Cohrs, R.J.; Mahalingam, R.; Nagel, M.A. Varicella zoster virus infection: Clinical
features, molecular pathogenesis of disease, and latency. Neurol. Clin. 2008, 26, 675–697. [CrossRef]
125. Tanaka, T.; Narazaki, M.; Kishimoto, T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb.
Perspect. Biol. 2014, 6, a016295. [CrossRef]
126. Yang, P.; Wen, H.; Ou, S.; Cui, J.; Fan, D. IL-6 promotes regeneration and functional recovery after cortical
spinal tract injury by reactivating intrinsic growth program of neurons and enhancing synapse formation.
Exp. Neurol. 2012, 236, 19–27. [CrossRef]
127. Yong, K.L. Granulocyte colony-stimulating factor (G-CSF) increases neutrophil migration across vascular
endothelium independent of an effect on adhesion: Comparison with granulocyte-macrophage
colony-stimulating factor (GM-CSF). Br. J. Haematol. 1996, 94, 40–47. [CrossRef]
128. Shaw, S.K.; Owolabi, S.A.; Bagley, J.; Morin, N.; Cheng, E.; LeBlanc, B.W.; Kim, M.; Harty, P.; Waxman, S.G.;
Saab, C.Y. Activated polymorphonuclear cells promote injury and excitability of dorsal root ganglia neurons.
Exp. Neurol. 2008, 210, 286–294. [CrossRef] [PubMed]
129. Jung, W.J.; Lee, S.Y.; Choi, S.I.; Kim, B.K.; Lee, E.J.; In, K.H.; Lee, M.G. Toll-like receptor expression in
pulmonary sensory neurons in the bleomycin-induced fibrosis model. PLoS ONE 2018, 13, e0193117.
[CrossRef]
130. Rietdijk, C.D.; Garssen, J.; Kraneveld, A.D. Neuronal toll-like receptors and neuro-immunity in Parkinson’s
disease, Alzheimer’s disease and stroke. Neuroimmunol. Neuroinflamm. 2016, 3, 27–37. [CrossRef]
131. Kim, D.; Kim, M.A.; Cho, I.H.; Kim, M.S.; Lee, S.; Jo, E.K.; Choi, S.Y.; Park, K.; Kim, J.S.; Akira, S.; et al.
A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain
hypersensitivity. J. Biol. Chem. 2007, 282, 14975–14983. [CrossRef]
132. Koyuncu, O.O.; Song, R.; Greco, T.M.; Cristea, I.M.; Enquist, L.W. The number of alphaherpesvirus particles
infecting axons and the axonal protein repertoire determines the outcome of neuronal infection. MBio 2015,
6, e00276-15. [CrossRef] [PubMed]
133. De Regge, N.; Van Opdenbosch, N.; Nauwynck, H.J.; Efstathiou, S.; Favoreel, H.W. Interferon alpha induces
establishment of alphaherpesvirus latency in sensory neurons in vitro. PLoS ONE 2010, 5, e13076. [CrossRef]
134. Pol, J.M.; Broekhuysen-Davies, J.M.; Wagenaar, F.; La Bonnardiere, C. The influence of porcine recombinant
interferon-alpha 1 on pseudorabies virus infection of porcine nasal mucosa in vitro. J. Gen. Virol. 1991, 72,
933–938. [CrossRef] [PubMed]
135. Van Opdenbosch, N.; De Regge, N.; Van Poucke, M.; Peelman, L.; Favoreel, H.W. Effects of interferon on
immediate-early mRNA and protein levels in sensory neuronal cells infected with herpes simplex virus type
1 or pseudorabies virus. Vet. Microbiol. 2011, 152, 401–406. [CrossRef] [PubMed]
Pathogens 2020, 9, 254 28 of 28
136. Song, R.; Koyuncu, O.O.; Greco, T.M.; Diner, B.A.; Cristea, I.M.; Enquist, L.W. Two Modes of the Axonal
Interferon Response Limit Alphaherpesvirus Neuroinvasion. MBio 2016, 7, e02145-15. [CrossRef]
137. Lamote, J.A.S.; Kestens, M.; Van Waesberghe, C.; Delva, J.; De Pelsmaeker, S.; Devriendt, B.; Favoreel, H.W. The
Pseudorabies Virus Glycoprotein gE/gI Complex Suppresses Type I Interferon Production by Plasmacytoid
Dendritic Cells. J. Virol. 2017, 91, e02276-16. [CrossRef]
138. Wang, J.; Wang, C.F.; Ming, S.L.; Li, G.L.; Zeng, L.; Wang, M.D.; Su, B.Q.; Wang, Q.; Yang, G.Y.; Chu, B.B.
Porcine IFITM1 is a host restriction factor that inhibits pseudorabies virus infection. Int. J. Biol. Macromol.
2019. [CrossRef] [PubMed]
139. Liu, H.; Li, S.; Yang, X.; Wang, X.; Li, Y.; Wang, C.; Chen, L.; Chang, H. Porcine ISG15 modulates the antiviral
response during pseudorabies virus replication. Gene 2018, 679, 212–218. [CrossRef] [PubMed]
140. Gnann, J.W., Jr. Varicella-zoster virus: Atypical presentations and unusual complications. J. Infect. Dis. 2002,
186, S91–S98. [CrossRef] [PubMed]
141. Kost, R.G.; Straus, S.E. Postherpetic neuralgia—Pathogenesis, treatment, and prevention. N. Engl. J. Med.
1996, 335, 32–42. [CrossRef] [PubMed]
142. Acosta, E.P.; Balfour, H.H., Jr. Acyclovir for treatment of postherpetic neuralgia: Efficacy and
pharmacokinetics. Antimicrob. Agents Chemother. 2001, 45, 2771–2774. [CrossRef] [PubMed]
143. Bennett, G.J.; Watson, C.P. Herpes zoster and postherpetic neuralgia: Past, present and future. Pain Res.
Manag. 2009, 14, 275–282. [CrossRef]
144. Latremoliere, A.; Woolf, C.J. Central sensitization: A generator of pain hypersensitivity by central neural
plasticity. J. Pain 2009, 10, 895–926. [CrossRef]
145. Semionov, V.; Shvartzman, P. Post herpetic itching—A treatment dilemma. Clin. J. Pain 2008, 24, 366–368.
[CrossRef]
146. Haberthur, K.; Messaoudi, I. Animal models of varicella zoster virus infection. Pathogens 2013, 2, 364–382.
[CrossRef]
147. Jarosinski, K.W.; Carpenter, J.E.; Buckingham, E.M.; Jackson, W.; Knudtson, K.; Moffat, J.F.; Kita, H.; Grose, C.
Cellular Stress Response to Varicella-Zoster Virus Infection of Human Skin Includes Highly Elevated
Interleukin-6 Expression. Open Forum. Infect. Dis. 2018, 5, ofy118. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
